Skip to main content Back to Top
Advertisement

8/29/2019

Argatroban Injection

Products Affected - Description

    • Argatroban intravenous injection, AuroMedics, 1 mg/mL, 50 mL vial, 10 count, NDC 55150-0241-10
    • Argatroban intravenous injection, Chiesi, 1 mg/mL, 50 mL vial, 10 count, NDC 42367-0203-84
    • Argatroban intravenous injection, Pfizer, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00409-1140-01
    • Argatroban intravenous injection, Sandoz, 1 mg/mL, 50 mL vial, 10 count, NDC 00781-3314-95 - discontinued

Reason for the Shortage

    • AuroMedics did not provide a reason for the shortage.
    • Chiesi did not provide a reason for the shortage.
    • Fresenius Kabi has argatroban available.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional refuses to provide availability information.
    • Par has argatroban available.
    • Pfizer has argatroban on shortage due to manufacturing delay.
    • Sandoz discontinued argatroban 1 mg/mL 50 mL vials in April 2019.
    • Teva has argatroban temporarily unavailable.

Available Products

    • Argatroban intravenous injection, Fresenius Kabi, 100 mg/mL, 2.5 mL vial, 1 count, NDC 63323-0526-03
    • Argatroban intravenous injection, Hikma, 1 mg/mL, 50 mL vial, 1 count, NDC 00143-9559-01
    • Argatroban intravenous injection, Hikma, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00143-9674-01
    • Argatroban intravenous injection, Novartis, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00078-0930-61
    • Argatroban intravenous injection, Par Pharmaceuticals, 100 mg/mL, 2.5 mL vial, 1 count, NDC 42023-0182-01
    • Argatroban intravenous injection, Sandoz, 1 mg/mL, 125 mL vial, 2 count, NDC 00781-3285-12

Estimated Resupply Dates

    • AuroMedics has argatroban 1 mg/mL 50 mL vials on intermittent back order.
    • Chiesi has argatroban 1 mg/mL 50 mL vials on back order and the company cannot estimate a release date.
    • Pfizer has argatroban 100 mg/mL 2.5 mL vials available in limited supply.

Updated

Updated August 29, 2019 by Megan Dryer, PharmD. Created November 20, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins